GlobeStar Therapeutics Corp: 10-Q filed 2020-07-14
What GlobeStar Therapeutics Corp reported in its quarterly report filed 2020-07-14 (fiscal Q3 2020): 24 published measures, 67 facts as tagged in accession 0001161697-20-000310.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2020-07-14
- Fiscal period
- fiscal Q3 2020
- Accession
- 0001161697-20-000310 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GlobeStar Therapeutics Corp filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 93,400 | USD | |
| At 2019-09-30 | 142,183 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 714,505 | USD | |
| At 2019-09-30 | 827,618 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | -621,105 | USD | |
| At 2020-03-31 | -605,220 | USD | |
| At 2019-12-31 | -616,868 | USD | |
| At 2019-09-30 | -685,435 | USD | |
| At 2019-06-30 | -727,747 | USD | |
| At 2019-03-31 | -843,171 | USD | |
| At 2018-12-31 | -844,512 | USD | |
| At 2018-09-30 | -870,731 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 50,319 | USD | |
| At 2019-09-30 | 100,459 | USD | |
| At 2019-06-30 | 104,783 | USD | |
| At 2018-09-30 | 91,597 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-06-30 | -87,985 | USD | 91 |
| 2019-10-01 to 2020-06-30 | -367,334 | USD | 274 |
| 2020-01-01 to 2020-03-31 | -118,312 | USD | 91 |
| 2019-10-01 to 2019-12-31 | -161,037 | USD | 92 |
| 2019-04-01 to 2019-06-30 | -540 | USD | 91 |
| 2018-10-01 to 2019-06-30 | -519,046 | USD | 273 |
| 2019-01-01 to 2019-03-31 | -190,263 | USD | 90 |
| 2018-10-01 to 2018-12-31 | -328,243 | USD | 92 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2020-06-30 | -170,358 | USD | 274 |
| 2018-10-01 to 2019-06-30 | -195,814 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2020-06-30 | 1,782 | USD | 274 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2020-06-30 | 77 | USD | 274 |
| 2019-04-01 to 2019-06-30 | 25 | USD | 91 |
| 2018-10-01 to 2019-06-30 | 300 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2020-06-30 | 122,000 | USD | 274 |
| 2018-10-01 to 2019-06-30 | 209,000 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2020-06-30 | -1,782 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | -7,040,941 | USD | |
| At 2019-09-30 | -6,673,607 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 1,435 | USD | |
| At 2019-09-30 | 822 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2019-06-30 | 68,250 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-06-30 | -48,563 | USD | 91 |
| 2019-10-01 to 2020-06-30 | -174,185 | USD | 274 |
| 2019-04-01 to 2019-06-30 | -53,859 | USD | 91 |
| 2018-10-01 to 2019-06-30 | -254,040 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 91,965 | USD | |
| At 2019-09-30 | 141,361 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-06-30 | 39,422 | USD | 91 |
| 2019-10-01 to 2020-06-30 | 193,149 | USD | 274 |
| 2019-04-01 to 2019-06-30 | 52,831 | USD | 91 |
| 2018-10-01 to 2019-06-30 | 239,609 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 714,505 | USD | |
| At 2019-09-30 | 827,618 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 40,081 | USD | |
| At 2019-09-30 | 40,115 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2020-06-30 | 63 | USD | 274 |
| 2019-04-01 to 2019-06-30 | 16 | USD | 91 |
| 2018-10-01 to 2019-06-30 | 244 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 383,120,160 | shares | |
| At 2019-09-30 | 170,467,283 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 6,034,819 | USD | |
| At 2019-09-30 | 1,225,272 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-06-30 | 48,563 | USD | 91 |
| 2019-10-01 to 2020-06-30 | 174,248 | USD | 274 |
| 2019-04-01 to 2019-06-30 | 53,875 | USD | 91 |
| 2018-10-01 to 2019-06-30 | 254,284 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2020-06-30 | 1,169 | USD | 274 |
| 2018-10-01 to 2019-06-30 | 354 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2020-06-30 | -34 | USD | 274 |
| 2018-10-01 to 2019-06-30 | 19,905 | USD | 273 |
Inspect the source
- Entity
- GlobeStar Therapeutics Corp / CIK 0001502152
- Captured
- 2026-09-21T17:19:31.788Z
- SEC response SHA-256
6be36a03e8f75354b6b3cf653d7b4e1bb0d8a85378e8b575eedf967d0fac66f7
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001502152.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))